ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
01 1ICE SpA
02 1Arch Pharmalabs Limited
03 1Daewoong Bio Inc.
04 1Daewoong Bio Inc._3rd Plant
05 1Darmerica, LLC
06 4Dipharma Francis Srl
07 1Fagron Inc
08 1Glenmark Life Sciences Limited
09 1Kalchem International inc
10 1LETCO MEDICAL, LLC
11 1Medisca Inc.
12 1Professional Compounding Centers of America dba PCCA
13 1Sichuan Huigukang Biological Technology Co., Ltd.
14 1Sichuan Xieli Pharmaceutical Co., Ltd.
15 1Spectrum Laboratory Products, Inc.
01 3URSODIOL
02 1URSODIOL (Process II)
03 2Ursodeoxycholic Acid
04 10Ursodiol
05 1Ursodiol (Process IV)
06 1ursodiol
01 2China
02 2India
03 5Italy
04 1Netherlands
05 2South Korea
06 5U.S.A
07 1United Kingdom
ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
NDC Package Code : 49345-2612
Start Marketing Date : 2002-05-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 22365-012
Start Marketing Date : 2018-12-17
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0089
Start Marketing Date : 1994-10-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0090
Start Marketing Date : 2005-11-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0653
Start Marketing Date : 2018-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0654
Start Marketing Date : 2005-11-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-0906
Start Marketing Date : 2004-09-01
End Marketing Date : 2027-07-11
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 38779-1987
Start Marketing Date : 2014-06-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-2909
Start Marketing Date : 1999-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-8085
Start Marketing Date : 2000-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Ursodeoxycholic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ursodeoxycholic Acid, including repackagers and relabelers. The FDA regulates Ursodeoxycholic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ursodeoxycholic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ursodeoxycholic Acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ursodeoxycholic Acid supplier is an individual or a company that provides Ursodeoxycholic Acid active pharmaceutical ingredient (API) or Ursodeoxycholic Acid finished formulations upon request. The Ursodeoxycholic Acid suppliers may include Ursodeoxycholic Acid API manufacturers, exporters, distributors and traders.
click here to find a list of Ursodeoxycholic Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ursodeoxycholic Acid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ursodeoxycholic Acid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ursodeoxycholic Acid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ursodeoxycholic Acid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ursodeoxycholic Acid NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ursodeoxycholic Acid suppliers with NDC on PharmaCompass.
We have 15 companies offering Ursodeoxycholic Acid
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
